Patient-Friendly Explanation

A generic medicine contains the same active ingredient as the original brand and is sold after the original’s patent expires, usually at a lower price. Biosimilars are the equivalent for medicines made from living cells, such as insulin and some injectable hormones; they are highly similar but not identical copies. Both are checked for quality and safety, although how they are supplied, stored and dosed can differ from the original.

Clinical Definition

Generics are approved on demonstration of pharmaceutical equivalence and bioequivalence within accepted confidence intervals, whereas biosimilars require comparative analytical, functional, preclinical and clinical similarity to a licensed reference product, with extrapolation to other indications granted by the regulator. In weight management, generic oral agents such as metformin and orlistat are widely substituted, while injectable peptides are biologics for which biosimilar availability, cold-chain handling and device design vary between products. Substitution rules differ by jurisdiction, and any switch should be accompanied by device training and monitoring for tolerability.

Why It Matters

Cost is one of the main reasons patients stop treatment, so knowing that a therapeutically equivalent option exists can keep therapy affordable, but patients should not assume a cheaper product behaves like the original, especially for injectables that need careful storage. NuLifeCare Singapore pharmacists check equivalence, storage and device technique whenever a patient switches products, so that saving money does not cost effectiveness.